GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Genprex, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$2.06−0.05 (-2.37%)
Close on Oct 19, 2026
- Market cap
- $974.71K
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Jul 16, 2026 | 1-for-22 reverse | Earlier per-share figures multiplied by 22 |
| Nov 14, 2025(first seen in filings) | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Oct 21, 2025 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Apr 1, 2024(first seen in filings) | 1-for-40 reverse | Earlier per-share figures multiplied by 40 |
| Feb 2, 2024 | 1-for-40 reverse | Earlier per-share figures multiplied by 40 |
| Apr 17, 2018(first seen in filings) | 34-for-1 | Earlier per-share figures divided by 34 |